PAR · ALTHE.PA
Theraclion S.A.
€0.71-€0.03 (-4.59%)
Theraclion S.A.’s quoted price sits in the upper half of its reported 52-week range, 24.09% below the high.
Loading market information…
OTC · ACNV · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Accelera Innovations, Inc’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Accelera Innovations, Inc. functions as a healthcare services provider, primarily engaged in developing Internet-based software solutions across the United States. Its core offering, Accelera Technology, is an online platform that aims to improve the efficiency and capabilities of healthcare services by making vital clinical health information accessible to consumers. In addition to its software, the company offers key support services such as billing, practice management, and administrative assistance to medical professionals and clinicians. It also provides home health services to patients in the Chicago area. Founded in 2008, the company changed its name from Accelerated Acquisitions IV, Inc. to Accelera Innovations, Inc. in October 2011 and is based in Colorado Springs, Colorado.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:17 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
€0.71-€0.03 (-4.59%)
Theraclion S.A.’s quoted price sits in the upper half of its reported 52-week range, 24.09% below the high.
$0.00$0.00 (0.0%)
Biostax Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Cognetivity Neurosciences Ltd.’s quoted price sits in the lower half of its reported 52-week range, 94.74% below the high.
$0.00$0.00 (0.0%)
Medite Cancer Diagnostics, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Ceres Ventures, Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.00$0.00 (0.0%)
Neurogenesis, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
ChromoCure, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.0% below the high.
$0.00$0.00 (0.0%)
GSRX Industries Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
